Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.
D000208:Acute Disease; D000367:Age Factors; D000917:Antibody Formation; D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D002353:Carrier State / Q000276:immunology; D002908:Chronic Disease; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006505:Hepatitis / Q000188:drug therapy / Q000276:immunology*; D006506:Hepatitis A / Q000276:immunology; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008113:Liver Neoplasms / Q000276:immunology*; D008297:Male; D011241:Prednisone / Q000494:pharmacology / Q000627:therapeutic use; D012737:Sex Factors; D000637:Transaminases / Q000097:blood
D006511:Hepatitis B Antigens; D007166:Immunosuppressive Agents; D003165:Complement System Proteins; D000637:Transaminases; D011241:Prednisone